This core will be responsible for managing the SPORE and disseminating information within the SPOREand for external interactions. The Core is designed for low-cost, yet efficient administration andcommunication in order to focus funds on research activities.The administrative component of the Core follows an organizational diagram for management activities.Monitoring of research will occur via 1) Research Project Teams, 2) Committee of Research ProjectInvestigators, 3) Core Investigators Committee, 4) Developmental Projects Program, 5) CareerDevelopment Committee, and 6) the central SPORE Steering Committee. An institutional Advisory Boardand External Advisory Board will provide yearly formal evaluations and reports to the Steering Committee.The communication component of the Core is directed at intra-SPORE, inter-SPORE, and National CancerInstitute research activities. The Core provides travel funds for Johns Hopkins Gl SPORE participation inthe NCI SPORE annual meetings, to include the SPORE Director/Pi, members of the Committee ofResearch Project Principal Investigators and other SPORE investigators. In addition, communication ofvalidated results to the medical community in order to impact on the incidence and mortality of colorectaland pancreatic cancer will occur via publication of SPORE findings in medical journals, occasional inter-institutional think tanks and organized public conferences through the Office of Continuing MedicalEducation of the Johns Hopkins Medical Institutions, news releases to medical writers and pressconferences for announcement of vital advances through the Office of Public Affairs of The Johns HopkinsMedical Institutions, and when appropriate, alerts coordinated through the NCI program staff.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
2P50CA062924-14
Application #
7246849
Study Section
Special Emphasis Panel (ZCA1-GRB-I (J1))
Project Start
2007-07-01
Project End
2012-06-30
Budget Start
2007-08-29
Budget End
2008-06-30
Support Year
14
Fiscal Year
2007
Total Cost
$127,778
Indirect Cost
Name
Johns Hopkins University
Department
Type
DUNS #
001910777
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Li, Yuguo; Qiao, Yuan; Chen, Hanwei et al. (2018) Characterization of tumor vascular permeability using natural dextrans and CEST MRI. Magn Reson Med 79:1001-1009
Saung, May Tun; Muth, Stephen; Ding, Ding et al. (2018) Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer. J Immunother Cancer 6:118
Canto, Marcia Irene; Almario, Jose Alejandro; Schulick, Richard D et al. (2018) Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance. Gastroenterology 155:740-751.e2
Makohon-Moore, Alvin P; Matsukuma, Karen; Zhang, Ming et al. (2018) Precancerous neoplastic cells can move through the pancreatic ductal system. Nature 561:201-205
Chu, Nam; Salguero, Antonieta L; Liu, Albert Z et al. (2018) Akt Kinase Activation Mechanisms Revealed Using Protein Semisynthesis. Cell 174:897-907.e14
Felsenstein, Matthäus; Noë, Michaël; Masica, David L et al. (2018) IPMNs with co-occurring invasive cancers: neighbours but not always relatives. Gut 67:1652-1662
Grant, Robert C; Denroche, Robert E; Borgida, Ayelet et al. (2018) Exome-Wide Association Study of Pancreatic Cancer Risk. Gastroenterology 154:719-722.e3
Tie, Jeanne; Cohen, Joshua D; Wang, Yuxuan et al. (2018) Serial circulating tumour DNA analysis during multimodality treatment of locally advanced rectal cancer: a prospective biomarker study. Gut :
Adler, B L; Pezhouh, M K; Kim, A et al. (2018) Histopathological and immunophenotypic features of ipilimumab-associated colitis compared to ulcerative colitis. J Intern Med 283:568-577
Ma, Qianqian; Gabelli, Sandra B; Raben, Daniel M (2018) Diacylglycerol kinases: Relationship to other lipid kinases. Adv Biol Regul :

Showing the most recent 10 out of 883 publications